Answer
Iodixanol (Visipaque), whose safety in human pregnancy is unestablished, should be used during pregnancy only if benefit outweighs risk and the physician considers it essential, avoiding radiation wherever possible and carefully weighing X-ray benefits against risks; thyroid monitoring is recommended in neonates exposed in utero.
Sources for this answer
- VISIPAQUE 320 mg I/ml Solution for Injection, glass container and polypropylene containerGE Healthcare Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked